turnaround like chief
thesi updat line guid optic
anyway wide rang manag think revenu
growth achiev follow turnaround year
view organ growth year low end
rang adjust adventist exit ablevet acquisit
still struggl growth come
book still declin manag expect full year
oper margin previou target
seem do-abl driven time initi
restructur compani seem shift focu
away core ehr busi indic like
shift portfolio year via mix
divestitur await clariti strateg
growth path updat long-term target come
investor day next month reiter rate price
target tweak ep estim slightli within
pleas see analyst certif import disclosur page report evercor isi affili seek busi
compani cover research report investor awar firm may conflict interest could affect object
report investor consid report singl factor make invest decis
take adventist revenu grow
return bn repo bn remain
declin year due declin lt book select outsourc
backlog primarili due termin revwork agreement
calcul exclud revenu contract termin claus even though
reduc book outsourc contract
lt book contract book vs last year
ramp annual revenu point
valuat methodolog base mix discount cash flow analysi rel valuat multipl
risk valuat includ regulatori risk overal market risk well unforeseen event relat individu cover
compani broader sector includ new competit product technolog
laboratori corp america
articl articl
time dissemin februari
analyst suzi yoon michael newshel primarili respons prepar research report attest follow
view opinion render research report reflect person view subject compani issuer part
research analyst compens directli relat specif recommend view research report
